{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:16:01Z","timestamp":1791951361570,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00213-021-05789-9","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T17:24:08Z","timestamp":1614446648000},"page":"1729-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2134-6436","authenticated-orcid":false,"given":"Stefanos","family":"Pittas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9810-7583","authenticated-orcid":false,"given":"Xenophon","family":"Theodoridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5100-8799","authenticated-orcid":false,"given":"Anna-Bettina","family":"Haidich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panteleimon-Vasilios","family":"Bozikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-9095","authenticated-orcid":false,"given":"Georgios","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"issue":"4","key":"5789_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/14734220601142878","volume":"6","author":"M Arakawa","year":"2007","unstructured":"Arakawa M, Ito Y (2007) N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 6(4):308\u2013314","journal-title":"Cerebellum"},{"issue":"1","key":"5789_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40345-019-0160-1","volume":"8","author":"RJ Baldessarini","year":"2020","unstructured":"Baldessarini RJ, V\u00e1zquez GH, Tondo L (2020) Bipolar depression: a major unsolved challenge. Int J Bipolar Disord 8(1):1","journal-title":"Int J Bipolar Disord"},{"key":"5789_CR3","doi-asserted-by":"crossref","unstructured":"Bauer IE, Green C, Colpo GD et al (2019) A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression. J Clin Psychiatry 80(1):18m12200","DOI":"10.4088\/JCP.18m12200"},{"issue":"6","key":"5789_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1399-5618.2007.00536.x","volume":"9","author":"M Berk","year":"2007","unstructured":"Berk M, Malhi GS, Catherine C, Catherine Carman A, Hadzi-Pavlovic D, Hawkins MT, Tohen M, Mitchell PB (2007) The bipolar depression rating scale (BDRS): its development, validation and utility. Bipolar Disord 9(6):571\u2013579","journal-title":"Bipolar Disord"},{"issue":"6","key":"5789_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biol Psychiatry 64(6):468\u2013475","journal-title":"Biol Psychiatry"},{"key":"5789_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1741-7015-10-91","volume":"10","author":"M Berk","year":"2012","unstructured":"Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, Kohlmann K, Jeavons S, Hewitt K, Moss K, Allwang C, Schapkaitz I, Cobb H, Bush AI, Dodd S, Malhi GS (2012) Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial. BMC Med 10:91","journal-title":"BMC Med"},{"key":"5789_CR7","doi-asserted-by":"crossref","unstructured":"Berk M, Turner A, Malhi GS et al (2019) Correction to: a randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med 17(1):35","DOI":"10.1186\/s12916-019-1280-2"},{"issue":"12","key":"5789_CR8","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1038\/tp.2014.129","volume":"4","author":"E Beurel","year":"2014","unstructured":"Beurel E, Jope RS (2014) Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits. Transl Psychiatry 4(12):e488","journal-title":"Transl Psychiatry"},{"issue":"11","key":"5789_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.euroneuro.2013.07.007","volume":"23","author":"KM Chitty","year":"2013","unstructured":"Chitty KM, Lagopoulos J, Lee RSC, Hickie IB, Hermens DF (2013) A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 23(11):1348\u20131363","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"12","key":"5789_CR10","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/S2215-0366(18)30422-X","volume":"5","author":"BM Cohen","year":"2018","unstructured":"Cohen BM, \u00d6ng\u00fcr D (2018) The urgent need for more research on bipolar depression. Lancet Psychiatry 5(12):e29\u2013e30","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"5789_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/jcph.1008","volume":"58","author":"LD Coles","year":"2018","unstructured":"Coles LD, Tuite PJ, \u00d6z G et al (2018) Repeated-dose oral N-acetylcysteine in Parkinson\u2019s disease: pharmacokinetics and effect on brain glutathione and oxidative stress. J Clin Pharmacol 58(2):158\u2013167","journal-title":"J Clin Pharmacol"},{"issue":"9995","key":"5789_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Collaborators, Global Burden of Disease Study 2013","year":"2015","unstructured":"Collaborators, Global Burden of Disease Study 2013 (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 386(9995):743\u2013800","journal-title":"Lancet (London, England)"},{"key":"5789_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pnpbp.2016.09.004","volume":"72","author":"J Data-Franco","year":"2017","unstructured":"Data-Franco J, Singh A, Popovic D, Ashton M, Berk M, Eduard V, Figueira ML, Dean OM (2017) Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology. Prog Neuro-Psychopharmacol Biol Psychiatry 72:73\u201386","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5789_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","volume":"55","author":"JS Deepmala","year":"2015","unstructured":"Deepmala JS, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R (2015) Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev 55:294\u2013321","journal-title":"Neurosci Biobehav Rev"},{"issue":"June 2018","key":"5789_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jad.2018.10.083","volume":"245","author":"PK Ellegaard","year":"2019","unstructured":"Ellegaard PK, Licht RW, Nielsen RE, Dean OM, Berk M, Poulsen HE, Mohebbi M, Nielsen CT (2019) The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: a randomized placebo-controlled study. J Affect Disord 245(June 2018):1043\u20131051","journal-title":"J Affect Disord"},{"issue":"2","key":"5789_CR16","first-page":"321","volume":"29","author":"J Endicott","year":"1993","unstructured":"Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29(2):321\u2013326","journal-title":"Psychopharmacol Bull"},{"issue":"4","key":"5789_CR17","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.4088\/JCP.15r09984","volume":"77","author":"BS Fernandes","year":"2016","unstructured":"Fernandes BS, Dean OM, Dodd S, Malhi GS, Berk M (2016) N-acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. J Clin Psychiatry 77(4):e457\u2013e466","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"5789_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bdi.12423","volume":"18","author":"AJ Ferrari","year":"2016","unstructured":"Ferrari AJ, Stockings E, Khoo J-P, Erskine HE, Degenhardt L, Vos T, Whiteford HA (2016) The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. Bipolar Disord 18(5):440\u2013450","journal-title":"Bipolar Disord"},{"issue":"10027","key":"5789_CR19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"I Grande","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, Vieta E (2016) Bipolar disorder. Lancet 387(10027):1561\u20131572","journal-title":"Lancet"},{"key":"5789_CR20","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert DD (2019) Dmetar: companion R package for the guide \u2018doing meta-analysis in R"},{"issue":"7414","key":"5789_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed) 327(7414):557\u2013560","journal-title":"BMJ (Clin Res Ed)"},{"key":"5789_CR22","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Li T, Deeks JJ (2019a) Choosing effect measures and computing estimates of effect. Cochrane Handbook for Systematic Reviews of Interventions 143\u2013176","DOI":"10.1002\/9781119536604.ch6"},{"key":"5789_CR23","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC (2019b) Assessing risk of bias in a randomized trial. Cochrane Handbook for Systematic Reviews of Interventions 205\u2013228","DOI":"10.1002\/9781119536604.ch8"},{"issue":"11","key":"5789_CR24","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1176\/appi.ajp.157.11.1858","volume":"157","author":"MJ Hilsenroth","year":"2000","unstructured":"Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, Price JL, Smith CL, Heindselman TL, Mount MK, Holdwick DJ Jr (2000) Reliability and validity of DSM-IV Axis V. Am J Psychiatry 157(11):1858\u20131863","journal-title":"Am J Psychiatry"},{"key":"5789_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF (2014) The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 14:25","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"5789_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1192\/bjp.166.5.654","volume":"166","author":"SH Jones","year":"1995","unstructured":"Jones SH, Thornicroft G, Coffey M, Dunn G (1995) A brief mental health outcome scale: reliability and validity of the global assessment of functioning (GAF). Br J Psychiatry 166(5):654\u2013659","journal-title":"Br J Psychiatry"},{"key":"5789_CR27","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1007\/s00213-020-05629-2","volume":"237","author":"T Kishi","year":"2020","unstructured":"Kishi T, Miyake N, Okuya M, Sakuma K, Iwata N (2020) N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials. Psychopharmacology. 237:3481\u20133487","journal-title":"Psychopharmacology."},{"issue":"4","key":"5789_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1017\/S0033291799008570","volume":"29","author":"AC Leon","year":"1999","unstructured":"Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB (1999) The Range of Impaired Functioning Tool (LIFE-RIFT): A brief measure of functional impairment. Psychol Med 29(4):869\u2013878","journal-title":"Psychol Med"},{"key":"5789_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jad.2017.09.042","volume":"226","author":"S Leucht","year":"2018","unstructured":"Leucht S, Fennema H, Engel RR et al (2018) Translating the HAM-D into the MADRS and vice versa with equipercentile linking. J Affect Disord 226:326\u2013331","journal-title":"J Affect Disord"},{"key":"5789_CR30","doi-asserted-by":"crossref","unstructured":"Magalh\u00e3es PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2011) N-acetylcysteine for major depressive episodes in bipolar disorder. Rev Bras Psiquiatr (Sao Paulo, Brazil\u202f: 1999) 33(4 CC-Common Mental Disorders):374\u2013378","DOI":"10.1590\/S1516-44462011000400011"},{"key":"5789_CR31","doi-asserted-by":"crossref","unstructured":"Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Rajesh S, Elisabeth Wells J, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241\u2013251","DOI":"10.1001\/archgenpsychiatry.2011.12"},{"issue":"1","key":"5789_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22\u201334","journal-title":"Nat Rev Immunol"},{"key":"5789_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci 134:382\u2013389","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"Pt A","key":"5789_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.01.014","volume":"74","author":"G Morris","year":"2017","unstructured":"Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M (2017) A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev 74(Pt A):1\u201320","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"5789_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/ijnp\/pyy018","volume":"21","author":"C Pereira","year":"2018","unstructured":"Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM (2018) Mitochondrial agents for bipolar disorder. Int J Neuropsychopharmacol 21(6):550\u2013569","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"5789_CR36","first-page":"31","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. Arch Gen Psychiatry 70(1):31\u201341","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"5789_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bdi.12373","volume":"18","author":"JD Rosenblat","year":"2016","unstructured":"Rosenblat JD, Kakar R, Berk M, Kessing LV, Vinberg M, Baune BT, Mansur RB, Brietzke E, Goldstein BI, Mcintyre RS (2016) Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord 18(2):89\u2013101","journal-title":"Bipolar Disord"},{"key":"5789_CR38","first-page":"40","volume":"7","author":"G Schwarzer","year":"2007","unstructured":"Schwarzer G (2007) Meta: an R package for meta-analysis. R News 7:40\u201345","journal-title":"R News"},{"issue":"2","key":"5789_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/pcn.12476","volume":"71","author":"E Sigitova","year":"2017","unstructured":"Sigitova E, Fi\u0161ar Z, Hroudov\u00e1 J, Cik\u00e1nkov\u00e1 T, Raboch J (2017) Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci 71(2):77\u2013103","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"5789_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","volume":"73","author":"MK Spearing","year":"1997","unstructured":"Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W (1997) Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73(3):159\u2013171","journal-title":"Psychiatry Res"},{"key":"5789_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajp.2017.03.019","volume":"28","author":"TR Soron","year":"2017","unstructured":"Soron TR (2017) Validation of bangla montgomery asberg depression rating scale (MADRSB). Asian J Psychiatr 28:41\u201346","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"5789_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","volume":"7","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, Kuss O, Higgins JPT, Langan D, Salanti G (2016) Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods 7(1):55\u201379","journal-title":"Res Synth Methods"},{"issue":"2","key":"5789_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O\u2019Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 Guidelines for the Management of Patients with Bipolar Disorder. Bipolar Disord 20(2):97\u2013170","journal-title":"Bipolar Disord"},{"key":"5789_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry J Ment Sci 133:429\u2013435","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"1","key":"5789_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00004850-200401000-00001","volume":"19","author":"M Zimmerman","year":"2004","unstructured":"Zimmerman M, Chelminski I, Posternak M (2004) A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol 19(1):1\u20137","journal-title":"Int Clin Psychopharmacol"},{"key":"5789_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Coello PA, Guyatt GH, Yepes-Nu\u00f1ez JJ, Akl EA, Hazlewood G, Pardo-Hernandez H, Etxeandia-Ikobaltzeta I, Qaseem A, Williams JW, Jr., Peter Tugwell, Signe Flottorp, Yaping Chang, Yuqing Zhang, Reem A. Mustafa, Mar\u00eda Ximena Rojas, Feng Xie, and Holger J. Sch\u00fcnemann. (2019) GRADE Guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences\u2014 inconsistency, imprecision, and other domains. J Clin Epidemiol 111:83\u201393","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"5789_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/acps.12862","volume":"137","author":"W Zheng","year":"2018","unstructured":"Zheng W, Zhang QE, Cai DB, Yang XH, Qiu Y, Ungvari GS, Ng CH, Berk M, Ning YP, Xiang YT (2018) N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Acta Psychiatr Scand 137(5):391\u2013400","journal-title":"Acta Psychiatr Scand"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05789-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T21:02:22Z","timestamp":1625518942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5789"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05789-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}